Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with childhood systemic lupus erythematosus: a real-world interventional multi-centre study (Q96162412): Difference between revisions
Jump to navigation
Jump to search
Revision as of 23:50, 21 February 2021
scientific article published on 05 June 2020
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with childhood systemic lupus erythematosus: a real-world interventional multi-centre study |
scientific article published on 05 June 2020 |
Statements
Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with childhood systemic lupus erythematosus: a real-world interventional multi-centre study (English)
Natalia Ferreira Pinto
Aline Lobo
Noortje Groot
Flavio Sztajnbok
Luciana B Paim Marques
Simone Appenzeller
Aline Garcia Islabão
Claudia Saad Magalhães
Rozana Gasparello de Almeida
Blanca Bica
Melissa Fraga
Aline Coelho Moreira da Fraga
Maria Carolina Dos Santos
Teresa Robazzi
Maria Teresa Ra Terreri
Marcia Bandeira
Hella Pasmans
Rutger Schepp
Fiona van der Klis
Sytze de Roock